S&P 500   4,352.63 (-2.04%)
DOW   34,299.99 (-1.63%)
QQQ   359.53 (-2.92%)
AAPL   141.83 (-2.44%)
MSFT   283.30 (-3.70%)
FB   340.45 (-3.71%)
GOOGL   2,718.74 (-3.64%)
TSLA   775.75 (-1.97%)
AMZN   3,316.98 (-2.61%)
NVDA   206.13 (-4.83%)
BABA   152.39 (+1.47%)
NIO   35.05 (-4.68%)
CGC   14.23 (-3.26%)
GE   105.72 (+0.35%)
MU   70.57 (-6.13%)
AMD   101.02 (-6.60%)
T   27.24 (-0.58%)
F   14.32 (+1.13%)
ACB   6.81 (+6.57%)
DIS   174.52 (-2.10%)
PFE   43.04 (-1.22%)
BA   218.41 (-2.57%)
AMC   36.82 (-6.31%)
S&P 500   4,352.63 (-2.04%)
DOW   34,299.99 (-1.63%)
QQQ   359.53 (-2.92%)
AAPL   141.83 (-2.44%)
MSFT   283.30 (-3.70%)
FB   340.45 (-3.71%)
GOOGL   2,718.74 (-3.64%)
TSLA   775.75 (-1.97%)
AMZN   3,316.98 (-2.61%)
NVDA   206.13 (-4.83%)
BABA   152.39 (+1.47%)
NIO   35.05 (-4.68%)
CGC   14.23 (-3.26%)
GE   105.72 (+0.35%)
MU   70.57 (-6.13%)
AMD   101.02 (-6.60%)
T   27.24 (-0.58%)
F   14.32 (+1.13%)
ACB   6.81 (+6.57%)
DIS   174.52 (-2.10%)
PFE   43.04 (-1.22%)
BA   218.41 (-2.57%)
AMC   36.82 (-6.31%)
S&P 500   4,352.63 (-2.04%)
DOW   34,299.99 (-1.63%)
QQQ   359.53 (-2.92%)
AAPL   141.83 (-2.44%)
MSFT   283.30 (-3.70%)
FB   340.45 (-3.71%)
GOOGL   2,718.74 (-3.64%)
TSLA   775.75 (-1.97%)
AMZN   3,316.98 (-2.61%)
NVDA   206.13 (-4.83%)
BABA   152.39 (+1.47%)
NIO   35.05 (-4.68%)
CGC   14.23 (-3.26%)
GE   105.72 (+0.35%)
MU   70.57 (-6.13%)
AMD   101.02 (-6.60%)
T   27.24 (-0.58%)
F   14.32 (+1.13%)
ACB   6.81 (+6.57%)
DIS   174.52 (-2.10%)
PFE   43.04 (-1.22%)
BA   218.41 (-2.57%)
AMC   36.82 (-6.31%)
S&P 500   4,352.63 (-2.04%)
DOW   34,299.99 (-1.63%)
QQQ   359.53 (-2.92%)
AAPL   141.83 (-2.44%)
MSFT   283.30 (-3.70%)
FB   340.45 (-3.71%)
GOOGL   2,718.74 (-3.64%)
TSLA   775.75 (-1.97%)
AMZN   3,316.98 (-2.61%)
NVDA   206.13 (-4.83%)
BABA   152.39 (+1.47%)
NIO   35.05 (-4.68%)
CGC   14.23 (-3.26%)
GE   105.72 (+0.35%)
MU   70.57 (-6.13%)
AMD   101.02 (-6.60%)
T   27.24 (-0.58%)
F   14.32 (+1.13%)
ACB   6.81 (+6.57%)
DIS   174.52 (-2.10%)
PFE   43.04 (-1.22%)
BA   218.41 (-2.57%)
AMC   36.82 (-6.31%)
NASDAQ:BLBD

Blue Bird Stock Forecast, Price & News

$20.34
-0.97 (-4.55 %)
(As of 09/28/2021 03:59 PM ET)
Add
Compare
Today's Range
$20.23
$21.15
50-Day Range
$19.23
$25.66
52-Week Range
$11.17
$28.90
Volume2,673 shs
Average Volume189,448 shs
Market Capitalization$553.33 million
P/E Ratio39.12
Dividend YieldN/A
Beta1.3
30 days | 90 days | 365 days | Advanced Chart
Receive BLBD News and Ratings via Email

Sign-up to receive the latest news and ratings for Blue Bird and its competitors with MarketBeat's FREE daily newsletter.


Blue Bird logo

About Blue Bird

Blue Bird Corp. engages in the design and manufacture of school buses. It operates through the Bus and Parts business segments. The Bus segment includes the manufacturing and assembly of school buses to be sold to a variety of customers across the United States, Canada, and in international markets. The Parts segment provides routine maintenance, replacement of parts that are damaged in service, and replacement of parts that suffer from wear and tear. The company was founded by Albert Laurence Luce in 1927 and is headquartered in Macon, GA.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Truck & bus bodies
Sub-Industry
N/A
Current Symbol
NASDAQ:BLBD
Employees
1,736
Year Founded
N/A

Sales & Book Value

Annual Sales
$879.22 million
Cash Flow
$1.31 per share
Book Value
($1.97) per share

Profitability

Net Income
$12.19 million

Debt

Price-To-Earnings

Miscellaneous

Market Cap
$553.33 million
Next Earnings Date
12/15/2021 (Estimated)
Optionable
Not Optionable

MarketRank

Overall MarketRank

2.52 out of 5 stars

Auto/Tires/Trucks Sector

18th out of 123 stocks

Truck & Bus Bodies Industry

1st out of 4 stocks

Analyst Opinion: 3.3Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 3.3Valuation: 1.9 5 -4 -3 -2 -1 -












Blue Bird (NASDAQ:BLBD) Frequently Asked Questions

Is Blue Bird a buy right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Blue Bird in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Blue Bird stock.
View analyst ratings for Blue Bird
or view top-rated stocks.

What stocks does MarketBeat like better than Blue Bird?

Wall Street analysts have given Blue Bird a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Blue Bird wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Blue Bird's next earnings date?

Blue Bird is scheduled to release its next quarterly earnings announcement on Wednesday, December 15th 2021.
View our earnings forecast for Blue Bird
.

How were Blue Bird's earnings last quarter?

Blue Bird Co. (NASDAQ:BLBD) announced its earnings results on Wednesday, August, 11th. The company reported $0.19 EPS for the quarter, missing the consensus estimate of $0.43 by $0.24. Blue Bird had a negative trailing twelve-month return on equity of 35.68% and a net margin of 1.82%.
View Blue Bird's earnings history
.

How has Blue Bird's stock been impacted by COVID-19?

Blue Bird's stock was trading at $14.85 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, BLBD stock has increased by 36.9% and is now trading at $20.33.
View which stocks have been most impacted by COVID-19
.

What guidance has Blue Bird issued on next quarter's earnings?

Blue Bird issued an update on its FY 2021 earnings guidance on Thursday, September, 9th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $730 million-$780 million, compared to the consensus revenue estimate of $816.80 million.

What price target have analysts set for BLBD?

2 brokerages have issued twelve-month target prices for Blue Bird's stock. Their forecasts range from $21.00 to $31.00. On average, they expect Blue Bird's share price to reach $26.00 in the next year. This suggests a possible upside of 27.9% from the stock's current price.
View analysts' price targets for Blue Bird
or view top-rated stocks among Wall Street analysts.

Who are Blue Bird's key executives?

Blue Bird's management team includes the following people:
  • Phil Horlock, Chief Executive Officer & Director
  • Matthew J. Stevenson, President
  • Charles R. Jenkins, Chief Operating Officer
  • Phil Tighe, Chief Financial Officer
  • Tom Roberts, Chief Administrative Officer

What is Phil Horlock's approval rating as Blue Bird's CEO?

12 employees have rated Blue Bird CEO Phil Horlock on Glassdoor.com. Phil Horlock has an approval rating of 49% among Blue Bird's employees. This puts Phil Horlock in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Blue Bird own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Blue Bird investors own include NVIDIA (NVDA), Alibaba Group (BABA), Advanced Micro Devices (AMD), AbbVie (ABBV), (CGC), Tesla (TSLA), Gilead Sciences (GILD), Marvell Technology (MRVL), Netflix (NFLX) and Roku (ROKU).

What is Blue Bird's stock symbol?

Blue Bird trades on the NASDAQ under the ticker symbol "BLBD."

Who are Blue Bird's major shareholders?

Blue Bird's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Alliancebernstein L.P. (8.06%), Price T Rowe Associates Inc. MD (6.95%), BlackRock Inc. (4.07%), Vanguard Group Inc. (3.35%), The Manufacturers Life Insurance Company (2.71%) and Lord Abbett & CO. LLC (2.23%). Company insiders that own Blue Bird stock include Asp Bb Holdings Llc, Paul Yousif and Phil Horlock.
View institutional ownership trends for Blue Bird
.

Which major investors are selling Blue Bird stock?

BLBD stock was sold by a variety of institutional investors in the last quarter, including Price T Rowe Associates Inc. MD, Renaissance Technologies LLC, BlackRock Inc., Lord Abbett & CO. LLC, Citadel Advisors LLC, Morgan Stanley, Morgan Stanley, and Willis Investment Counsel. Company insiders that have sold Blue Bird company stock in the last year include Asp Bb Holdings Llc, Paul Yousif, and Phil Horlock.
View insider buying and selling activity for Blue Bird
or view top insider-selling stocks.

Which major investors are buying Blue Bird stock?

BLBD stock was bought by a variety of institutional investors in the last quarter, including Alliancebernstein L.P., Lansdowne Partners UK LLP, State Street Corp, The Manufacturers Life Insurance Company , Blair William & Co. IL, Vanguard Group Inc., Brandywine Global Investment Management LLC, and Mitsubishi UFJ Kokusai Asset Management Co. Ltd..
View insider buying and selling activity for Blue Bird
or or view top insider-buying stocks.

How do I buy shares of Blue Bird?

Shares of BLBD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Blue Bird's stock price today?

One share of BLBD stock can currently be purchased for approximately $20.33.

How much money does Blue Bird make?

Blue Bird has a market capitalization of $553.06 million and generates $879.22 million in revenue each year. The company earns $12.19 million in net income (profit) each year or $0.70 on an earnings per share basis.

How many employees does Blue Bird have?

Blue Bird employs 1,736 workers across the globe.

What is Blue Bird's official website?

The official website for Blue Bird is www.blue-bird.com.

Where are Blue Bird's headquarters?

Blue Bird is headquartered at 3920 Arkwright Road 2nd Floor, Macon GA, 31210.

How can I contact Blue Bird?

Blue Bird's mailing address is 3920 Arkwright Road 2nd Floor, Macon GA, 31210. The company can be reached via phone at (478) 822-2801 or via email at [email protected].


This page was last updated on 9/28/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.